Marcus & Millichap (MMI) Q2 2026 Earnings Call Transcript

Marcus & Millichap reported Q2 2026 total revenue of $203M, up 18% YoY, with net income swinging to $4M ($0.10/share) versus a $11M net loss a year ago, and adjusted EBITDA improving to $12M from $1.5M. Brokerage revenue rose 18% to $167M (1,530 transactions, +11%) while financing revenue increased 15% to $30M on 480 loans (+17%). Management cited narrowing bid-ask spreads and 50 bps higher 10-year Treasury yields YTD contributing to longer timelines, but expects SG&A to rise modestly on a dollar basis in Q3 and declared a semiannual dividend of $0.25/share plus $24M of YTD share repurchases (913k shares).

Analysis

MMI is a levered expression of CRE transaction normalization, but the more important read-through is not the quarter itself; it is whether the company is crossing from a “volume recovery” into a “mix + leverage” recovery. Because the support stack is already built, incremental brokerage/financing flow should fall through well if deal velocity keeps improving, yet compensation is also rising at the top end, so margin expansion will lag revenue unless transaction counts keep compounding over multiple quarters. That makes this more of a 1-3 month catalyst story than an immediate rerating story.

The competitive takeaway is that fragmented local and regional intermediaries are likely the first losers: MMI’s lender network and integrated sales/financing loop are a structural advantage when buyers and sellers need certainty. The bigger second-order opportunity is in adjacent services — leasing, appraisal, and investment management — because those businesses reduce cycle dependence and increase wallet share, but they also carry execution risk and could dilute ROIC before they contribute meaningfully. Banks with CRE origination exposure such as MTB and WFC could see incremental fee flow if refinancing stays open, but that benefit is more modest than the direct brokerage operating leverage at MMI.

The contrarian risk is that consensus may be underestimating how fragile the recovery still is to rates: a modest move higher in the 10-year can delay closings by a quarter or two, which is enough to flatten near-term earnings momentum even if pipeline anecdotes remain constructive. The thesis is falsified if Q3 pipeline growth stalls or if transaction counts fail to re-accelerate despite “better” pricing. In that case, the stock becomes a capital-return story rather than a true cyclical rerate.

Key Decisions for Investors

• Long MMI on pullbacks for a 1-3 month trade: best risk/reward is to own the name into the next two prints if you believe transaction counts and financing mix continue to improve. Falsify the trade if management guides pipeline flat/down or if 10-year yields back up materially and closing timelines extend again.
• Treat MMI as a pair against a less-diversified CRE intermediary only if you can source the borrow; otherwise, keep it as a standalone long. The edge is MMI’s lender/refi loop and broader product set, which should outperform pure brokerage peers if transaction recovery remains choppy but positive.
• Watch MTB and WFC as secondary beneficiaries, not immediate longs: if CRE refinancing volumes keep rising for another quarter, fee income and cross-sell should improve, but the impact is slower and less convex than MMI. Use them as confirmation rather than the primary expression.
• No options until there is evidence that Q3 pipeline converts into closed volume. If the stock sells off on a strong headline quarter, that could be the better entry because the market is likely underpricing the sequential margin drag from higher cost of services.